Lin Health Raises $11M Series A to Transform Chronic Pain Care

Lin Health, a company dedicated to helping individuals reclaim their lives from chronic pain, has secured $11,000,000 in investment capital from investors.

This significant funding round will support the expansion of its human-led, tech-enabled, and highly personalized care model, which applies the latest neuroscience to address persistent pain conditions.

The company partners with payers and providers, integrating as an extension of their care teams to offer an affordable, immediately accessible, and non-pharmacological solution.

Lin Health's award-winning approach targets prevalent neuroplastic pain, treating conditions as diverse as migraines, IBS, and back and joint pain.

Its clinically validated intervention combines effective pain signaling techniques, multidisciplinary clinical guidance, high-frequency coaching, and evidence-based digital resources with proprietary technology.

The newly raised capital is intended to further develop and scale Lin Health's proprietary AI-based Care Platform, which has already served thousands of patients in the past 12 months, demonstrating rapid scalability.

These funds will enable the company to expand its operational capacity and enhance its comprehensive care programs, improving patient outcomes and satisfaction for both patients and providers, as well as clinic success.

This investment underscores confidence in Lin Health's distinctive approach to chronic pain management.

Looking ahead, the company plans to broaden its partnerships and extend the reach of its specialized care, making its innovative solution accessible to a greater number of individuals.

Lin Health aims to solidify its role as a key partner for health systems, clinics, and payers seeking effective and integrated pain management solutions.